Categories: News

Edison Issues Report on PCI-PAL (PCIP)

London, United Kingdom–(Newsfile Corp. – September 10, 2025) – Edison issues report on PCI-PAL (AIM: PCIP).

PCI Pal is a provider of cloud-based secure payment technology to the business communications market. The company has grown annual recurring revenue (ARR) at a fast pace over the last five years, helped by its channel-first strategy. After several years fighting patent litigation, which was ultimately resolved in PCI Pal’s favour in June 2024, the company is accelerating the pace of investment to drive ARR growth. The two areas for additional investment are marketing, both general and product related, to drive deeper engagement with key partners and attract more direct enterprise business; and product development to support the company’s plans to expand the product range and increase net revenue retention. Our ARR forecasts are in line with PCI Pal’s growth targets (18-20% to FY27 and beyond). We forecast a drop in EBITDA margins in FY26 to 2.8% as the extra investment is made, growing to 8.2% in FY27.

Click here to read the full report.

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265839

Staff

Recent Posts

TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

Key Commercialization Milestone in Retail Pharmacy Network that Serves Over 2.8 Million Insured MembersVancouver, British…

4 hours ago

NuGen Medical Devices Inc. Provides Update on Health Canada License

Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

13 hours ago

Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026

Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF-BY-THE-SEA, Calif., Feb. 5,…

13 hours ago

LEADOPTIK Announces First-in-Human Use of FDA-Cleared LIA™ System

SAN JOSE, Calif., Feb. 5, 2026 /PRNewswire/ -- LEADOPTIK, Inc., a medical technology company focused…

13 hours ago

Dräger PSS® AirBoss SCBA Now Available for Purchase in North America

Now Available for Purchase, AirBoss Delivers an NFPA 1970:2025 SCBA Built for the Way American…

19 hours ago

Greenway Health® Named Most Improved Physician Practice Solution 2026 by KLAS Research

KLAS recognition highlights Greenway's momentum in modernizing physician practice technologyTAMPA, Fla., Feb. 5, 2026 /PRNewswire/…

19 hours ago